IP Library Granted Patent US 7,368,269
Granted Patent B1
US 7,368,269 · App. 11/075,058 · Granted May 6, 2008

Crystallization of MAPK/ERK Kinase 2

Assignee: Takeda San Diego, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,368,269
App. No.
11/075,058
Granted
May 6, 2008
Kind
B1
Abstract

Provided are crystals relating to human mitogen-activated protein kinase kinase2 (MAPKK2), also known as MAPK/ERK Kinase2 (MEK2) and its various uses.

Claims (13)

1. A composition comprising a protein in crystalline form wherein the protein consists of SEQ ID NO:3, and wherein the protein crystal has a crystal lattice in a P2 1 space group and unit cell dimensions, +/−5%, of a=58.028 Å, b=43.442 Å, c=135.778 Å, α=90.0°, β=102.13°, γ=90.0°.

2. A composition according to claim 1 wherein the protein crystal diffracts X-rays for a determination of structure coordinates to a higher resolution than 3.0 Angstroms.

3. A composition according to claim 1 wherein the protein crystal diffracts X-rays for a determination of structure coordinates to a higher resolution than 2.5 Angstroms.

4. A composition comprising an isolated non-crystalline protein consisting of SEQ ID NO:3.

5. A composition comprising an isolated non-crystalline protein of claim 4 , wherein the protein is encoded by a nucleic acid molecule that consists of SEQ ID NO:2.

6. A method for forming a crystal of a protein comprising:

forming a crystallization volume comprising a precipitant solution and a protein that consists of SEQ ID NO:3, and

storing the crystallization volume under conditions suitable for crystal formation until a protein crystal is formed, wherein the protein crystal has a crystal lattice in a P2 1 space group and unit cell dimensions, +/−5%, of a=58.028 Å, b=43.442 Å, c=135.778 Å, α=90.0°, β=102.13°, γ=90.0°.

7. The method according to claim 6 wherein the protein crystal diffracts X-rays for a determination of structure coordinates to a higher resolution than 3.0 Angstroms.

8. The method according to claim 6 wherein the protein crystal diffracts X-rays for a determination of structure coordinates to a higher resolution than 2.5 Angstroms.

9. A method according to claim 6 , the method further comprising diffracting the protein crystal to produce a diffraction pattern.

10. The composition comprising a protein in crystalline form of claim 1 , wherein SEQ ID No: 3 is encoded by the nucleic acid of SEQ ID No: 2.

11. A non crystalline, isolated protein consisting of SEQ ID NO:3.

Assignments (2)
CHANGE OF NAME Recorded Aug 16, 2006
From: SYRX, INC.
To: TAKEDA SAN DIEGO, INC.
Reel/Frame 018132/0496 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 7, 2005
From: CRONIN, CIARAN N.; DOUGAN, DOUGLAS R.; KNUTH, MARK W.; KRAUS, MICHELLE L.; LIM, KHENG; MOL, CLIFFORD D.; SNELL, GYORGY; ZOU, HUA
To: SYRRX, INC.
Reel/Frame 016373/0708 →